Emerg Infect Dis. 2018 May;24(5):888-92. doi: 10.3201/eid2405.171747. Epub 2018 May 17.
We conducted an external quality assessment of Zika virus molecular diagnostic tests in Brazil using a new Zika virus standard. Of 15 laboratories, 73% showed limited sensitivity and specificity. Viral load estimates varied significantly. Continuous quality assurance is needed to adequately estimate risk for Zika virus-associated disease and determine patient care.
我们使用新的 Zika 病毒标准对巴西的 Zika 病毒分子诊断检测进行了外部质量评估。在 15 个实验室中,有 73%的实验室显示出有限的灵敏度和特异性。病毒载量估计值差异显著。需要持续的质量保证,以充分评估与 Zika 病毒相关疾病的风险,并确定患者的治疗方案。